DA-1229_01
Sponsors
Dong-A ST Co., Ltd.
Conditions
HealthyType 2 Diabetes Mellitus
Phase 1
A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers
CompletedNCT02167061
Start: 2014-07-31End: 2014-11-30Updated: 2014-12-02
A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers
CompletedNCT02375139
Start: 2015-04-30End: 2015-06-30Updated: 2015-07-22
Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State
CompletedNCT07297940
Start: 2025-12-14End: 2026-01-31Updated: 2026-03-31
Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State
CompletedNCT07342062
Start: 2026-01-06End: 2026-02-14Updated: 2026-04-07